Uswm Ct, Llc

This study tests whether genetically modified immune cells can safely shrink tumors in people with advanced synovial sarcoma or liposarcoma. Researchers collect patients' own T-cells, engineer them to recognize cancer proteins, then infuse them back into the body. The trial is fo…

This early-stage trial is testing the safety of a new treatment called ADP-A2M4CD8, which uses a patient's own modified immune cells to fight cancer. The study will enroll 120 adults with one of nine advanced cancers who have specific genetic markers. Researchers will give the ce…

This study is testing whether a personalized immune cell therapy can help control advanced synovial sarcoma or myxoid liposarcoma. Doctors take a patient's own immune cells, genetically modify them to recognize cancer, and infuse them back. The trial will measure how well tumors …

This study tests an experimental treatment called Lete-Cel, which uses a patient's own genetically modified immune cells to fight two types of advanced soft tissue cancer: synovial sarcoma and myxoid/round cell liposarcoma. It involves 87 participants whose cancers have progresse…

This study is testing a new personalized treatment for ovarian cancer that has come back. Doctors take a patient's own immune cells, modify them in a lab to better target the cancer, and then infuse them back. The trial is seeing if these modified cells work better alone or when …